RELIVE LIFE SCIENCES LIMITED – Trademark Portfolio
Entity Type: 03
RELIVE LIFE SCIENCES LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SPHEROX. The owner is based in NEWTON, MA.
55 CHAPEL ST., SUITE 100
NEWTON, MA 02458
Showing of trademarks Trademarks
Trademark Classifications
RELIVE LIFE SCIENCES LIMITED's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does RELIVE LIFE SCIENCES LIMITED have?
RELIVE LIFE SCIENCES LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does RELIVE LIFE SCIENCES LIMITED file in?
RELIVE LIFE SCIENCES LIMITED files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are RELIVE LIFE SCIENCES LIMITED's most well-known trademarks?
RELIVE LIFE SCIENCES LIMITED's registered trademark portfolio includes well-known marks such as SPHEROX. These are among 1 currently registered trademark in the portfolio.
What is RELIVE LIFE SCIENCES LIMITED's trademark registration success rate?
RELIVE LIFE SCIENCES LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.